Meclofenamate Sodium
CAS No. 6385-02-0
Meclofenamate Sodium( Meclofenamic Acid )
Catalog No. M15422 CAS No. 6385-02-0
A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 30 | In Stock |
|
50MG | 41 | In Stock |
|
100MG | 69 | In Stock |
|
200MG | 113 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMeclofenamate Sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionA non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
-
DescriptionA non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
-
In VitroCell Cycle Analysis Cell Line:haSMCs Concentration:10, 100, 200 mM Incubation Time:4 days Result:Caused a G2/M-phase block Western Blot Analysis Cell Line:haSMCs Concentration:10, 100, 200 mM Incubation Time:4 days Result:Decreased the expression of p44/42 MAPK.
-
In VivoAnimal Model:Prostate tumor model in mice Dosage:10 mg/kg Administration:i.p.Result:Decreased tumor aggression, increased fibrosis, cellular proliferation and vascularity reduction.
-
SynonymsMeclofenamic Acid
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1| COX-2
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number6385-02-0
-
Formula Weight318.14
-
Molecular FormulaC14H10Cl2NNaO2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 63 mg/mL (198.03 mM); Water: 63 mg/mL (198.03 mM); DMSO: 63 mg/mL (198.03 mM)
-
SMILESCC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Soriano-Hernández AD, et al. Int Urol Nephrol. 2012 Apr;44(2):471-7.
molnova catalog
related products
-
ASP-6537
ASP-6537 (ASP6537) is a novel potent, selective, reversible cyclooxygenase-1 (COX-1) inhibitor with IC50 of 4.9 nM.
-
Pasiniazid
Pasiniazid is an anti-TB and anti-leprosy drug, used to treat various types of TB and leprosy.
-
Agnuside
Agnuside inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3 66.8 and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5 25 and 100 μM respectively.